---
title: "Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304008064.md"
description: "Bambusa Therapeutics director Helmut Wolfgang Jeggle acquired 375,000 common shares at $16 each, totaling $6 million. This purchase brings his indirect common stock holdings to 9,264,301 shares, which includes 4,769,701 shares obtained through preferred stock conversion. The transaction was reported via EDGAR on November 2, 2026."
datetime: "2026-11-02T21:07:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304008064.md)
  - [en](https://longbridge.com/en/news/304008064.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304008064.md)
generator: "portal-rs"
---

# Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition

-   Bambusa Therapeutics director Helmut Wolfgang Jeggle purchased 375,000 common shares at $16 each. \* Indirect common stock holdings reached 9,264,301 shares, including 4,769,701 shares acquired through preferred stock conversion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bambusa Therapeutics, Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001982614-26-000004), on November 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [Bambusa Therapeutics Grants CEO Shanshan Xu 758,204 Performance-Based Restricted Stock Units](https://longbridge.com/en/news/304007383.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)
- [Ferrari Group Announces Acquisition of Remaining 50% Stake in Americas](https://longbridge.com/en/news/306002876.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**